Until the 1990s, it was generally accepted that medicines were first developed for adults and their use in children was investigated later, if at all. One of th

The development of paediatric medicines can be challenging since this is a different patient population with specific needs. A medicine designed for use in paed

Now even more comprehensive, this fourth edition of Extemporaneous Formulations provides the same evidence-based formulation in easy-to-follow 'recipes' for 312

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used fo